Progress on the molecular anti-tumor mechanisms of arctigenin

doi:10.3969/j.issn.1673-8640.2016.06.022

Abstract

CLC Number:

R446.1

HUANG Dongdong, CAI Zhiyi. Progress on the molecular anti-tumor mechanisms of arctigenin[J]. Laboratory Medicine, 2016, 31(6): 546-548.

References 21

[1]	米靖宇,宋纯清. 牛蒡子中木脂素类化合物的抗肿瘤及免疫活性[J]. 时珍国医国药,2002,13(3):168-169.
[2]	TSAI WJ, CHANG CT, WANG GJ, et al.Arctigenin from Arctium lappa inhibits interleukin-2 and interferon gene expression in primary human T lymphocytes[J]. Chin Med,2011,6(1):12.
[3]	TANG X,ZHUANG J,CHEN J,et a1. Arctigenin efficiently enhanced sedentary mice treadmill endurance[J]. PLoS One,2011,6(8):e24224.
[4]	赵辉,袁莉,贾莉,等. 牛蒡子苷元对高糖刺激大鼠系膜细胞转化生长因子β1表达的影响[J]. 泰山医学院学报,2013,34(8):611-612.
[5]	GU Y,QI C,SUN X,et al.Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism[J].Biochem Pharmacol,2012,84(4):468-476.
[6]	KUDOU N,TANIGUCHI A,SUGIMOTO K,et al.Synthesis and antitumor evaluation of arctigenin derivatives based on antiausterity strategy[J]. Eur J Med Chem,2013,60:76-88.
[7]	TEZUKA Y,YAMAMOTO K,AWALE S,et al.Anti-austeric activity of phenolic constituents of seeds of Arctium lappa[J]. Nat Prod Commun, 2013,8(4):463-466.
[8]	AWALE S,KATO M,DIBWE DF,et al.Antiausterity activity of arctigenin enantiomers: importance of (2R,3R)-absolute configuration[J]. Nat Prod Commun,2014,9(1):79-82.
[9]	UMEHARA K,NAKAMURA M,MIYASE T,et al.Studies on differentiation inducers. Ⅵ. Lignan derivatives from Arctium fructus. (2)[J]. Chem Pharm Bull(Tokyo),1996,44(12):2300-2304.
[10]	SUSANTI S,IWASAKI H,INAFUKU M,et al.Mechanism of arctigenin-mediated specific cytotoxicity against human lung adenocarcinoma cell lines[J]. Phytomedicine,2013,21(1):39-46.
[11]	YANG S,MA J,XIAO J, et al.Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis[J]. Anat Rec(Hoboken),2012,295(8):1260-1266.
[12]	KANG K,LEE HJ,YOO JH,et al.Cell and nuclear enlargement of SW480 cells induced by a plant lignan, arctigenin: evaluation of cellular DNA content using fluorescence microscopy and flow cytometry[J]. DNA Cell Biol,2011,30(8):623-629.
[13]	JEONG JB,HONG SC,JEONG HJ,et al.Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells[J]. Int Immunopharmacol,2011,11(10):1573-1577.
[14]	WYLLIE AH."Where,O death,is thy sting?" A brief review of apoptosis biology[J]. Mol Neurobiol,2010,42(1):4-9.
[15]	HSIEH CJ,KUO PL,HSU YC,et al.Arctigenin,a dietary phytoestrogen,induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation[J]. Free Radic Biol Med, 2014 ,67:159-170.
[16]	YOO JH,LEE HJ,KANG K,et al.Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling[J]. Food Chem Toxicol,2010,48(8-9):2247-2252.
[17]	GU Y,SCHEUER C,FENG D,et al.Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin[J]. Anticancer Drugs,2013,24(8):781-791.
[18]	WANG HQ,JIN JJ,WANG J.Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression[J]. J Biochem Mol Toxicol,2014,28(1):39-45.
[19]	SUN S,WANG X,WANG C,et al.Arctigenin suppresses unfolded protein response and sensitizes glucose deprivation-mediated cytotoxicity of cancer cells[J]. Planta Med,2011,77(2):141-145.
[20]	朱孔梅. 牛蒡苷元联合替吉奥对H22荷瘤小鼠的抑瘤作用[J]. 山东医学高等专科学校学报,2013,35(5):333-335.
[21]	CHO JY,KIM AR,YOO ES,et al.Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-alpha and nitric oxide production, and lymphocyte proliferation[J]. J Pharm Pharmacol, 1999 ,51(11):1267-1273.

Progress on the molecular anti-tumor mechanisms of arctigenin

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 21

Related Articles 15

Recommended Articles

Metrics

[1]	GAO Zikang, CHEN Jing. Construction of a nomogram prediction model for the prognosis of patients with depressive disorder based on the characteristics of peripheral blood lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(12): 1146-1152.
[2]	WANG Tian, ZHANG Yun, BAI Yi, ZHAI Weibin, ZHAO Hai. Roles of PIV，SII and NPAR in the diagnosis of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites [J]. Laboratory Medicine, 2025, 40(12): 1153-1158.
[3]	HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.
[4]	LI Minghong, MIN Cuili, GUO Qingbo, MA Lujuan. Predictive roles of serum 25（OH）D and SAA for the response to immunosuppressive therapy in autoimmune hepatitis [J]. Laboratory Medicine, 2025, 40(12): 1165-1170.
[5]	ZHEN Di, JIA Bin, MENG Xianyi. Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment [J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
[6]	ZHAO Yilin, XU Yan, YIN Hui. Roles of serum miR-145-5p，miR-200C-3p and miR-1290 in prognosis assessment of patients with papillary thyroid carcinoma [J]. Laboratory Medicine, 2025, 40(12): 1177-1182.
[7]	LI Song, XIANG Xu. Risk factors for poor prognosis in elderly patients with severe fever and thrombocytopenia syndrome and their clinical significance [J]. Laboratory Medicine, 2025, 40(12): 1183-1189.
[8]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[9]	. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.
[10]	. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.
[11]	. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.
[12]	BAO Wen. Application and prospect of microsatellite instability determination in tumor diagnosis and treatment [J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
[13]	XIONG Ying, GUO Wei. From generic to personalized：the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041.
[14]	CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis [J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
[15]	LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.